Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2014, Article ID 376918, 16 pages
http://dx.doi.org/10.1155/2014/376918
Research Article

Effects of Human Mesenchymal Stem Cells Isolated from Wharton’s Jelly of the Umbilical Cord and Conditioned Media on Skeletal Muscle Regeneration Using a Myectomy Model

1Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, No. 228, 4050-313 Porto, Portugal
2Centro de Estudos de Ciência Animal (CECA), Instituto de Ciências e Tecnologias Agrárias e Agro-Alimentares (ICETA), Rua D. Manuel II, Apartado 55142, 4051-401 Porto, Portugal
3Faculdade de Motricidade Humana (FMH), Universidade de Lisboa (UL), Estrada da Costa, 1499-002 Cruz Quebrada—Dafundo, Portugal
4CIPER-FMH: Centro Interdisciplinar de Estudo de Performance Humana, Faculdade de Motricidade Humana (FMH), Universidade de Lisboa (UL), Estrada da Costa, 1499-002 Cruz Quebrada, Dafundo, Portugal
5Departamento de Patologia e de Imunologia Molecular, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, No. 228, 4050-313 Porto, Portugal
6Instituto Português de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP), Rua Dr. Roberto Frias s/n, 4200-465 Porto, Portugal
7CDRsp-Centro Para o Desenvolvimento Rápido e Sustentado de Produto, Instituto Politécnico de Leiria, Rua de Portugal, Zona Industrial, 2430-028 Marinha Grande, Portugal
8CEMUC, Departamento de Engenharia Metalúrgica e Materiais, Faculdade de Engenharia, Universidade do Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal
9UPVET, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, No. 228, 4050-313 Porto, Portugal

Received 18 July 2014; Revised 21 August 2014; Accepted 22 August 2014; Published 14 October 2014

Academic Editor: Pranela Rameshwar

Copyright © 2014 T. Pereira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Matziolis, T. Winkler, K. Schaser et al., “Autologous bone marrow-derived cells enhance muscle strength following skeletal muscle crush injury in rats,” Tissue Engineering, vol. 12, no. 2, pp. 361–367, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. L. Page, C. Malcuit, L. Vilner et al., “Restoration of skeletal muscle defects with adult human cells delivered on fibrin microthreads,” Tissue Engineering A, vol. 17, no. 21-22, pp. 2629–2640, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Quintero, V. J. Wright, F. H. Fu, and J. Huard, “Stem cells for the treatment of skeletal muscle injury,” Clinics in Sports Medicine, vol. 28, no. 1, pp. 1–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. E. K. Merritt, D. W. Hammers, M. Tierney, L. J. Suggs, T. J. Walters, and R. P. Farrar, “Functional assessment of skeletal muscle regeneration utilizing homologous extracellular matrix as scaffolding,” Tissue Engineering—Part A, vol. 16, no. 4, pp. 1395–1405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Pereira, A. Gärtner, I. Amorim et al., “Biomaterials and stem cell therapies for injuries associated to skeletal muscular tissues,” in Advances in Biomaterials Science and Biomedical Applications, R. Pignatello, Ed., InTech, 2013. View at Google Scholar
  6. Y. Li and J. Huard, “Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle,” The American Journal of Pathology, vol. 161, no. 3, pp. 895–907, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Menetrey, C. Kasemkijwattana, C. S. Day et al., “Growth factors improve muscle healing in vivo,” Journal of Bone and Joint Surgery-Series B, vol. 82, no. 1, pp. 131–137, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Sato, Y. Li, W. Foster et al., “Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis,” Muscle and Nerve, vol. 28, no. 3, pp. 365–372, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Grabowska, W. Streminska, K. Janczyk-Ilach et al., “Myogenic potential of mesenchymal stem cells—the case of adhesive fraction of human umbilical cord blood cells,” Current Stem Cell Research and Therapy, vol. 8, no. 1, pp. 82–90, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Krampera, G. Pizzolo, G. Aprili, and M. Franchini, “Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair,” Bone, vol. 39, no. 4, pp. 678–683, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. N. T. Ninagawa, E. Isobe, Y. Hirayama et al., “Transplantated mesenchymal stem cells derived from embryonic stem cells promote muscle regeneration and accelerate functional recovery of injured skeletal muscle,” BioResearch Open Access, vol. 2, no. 4, pp. 295–306, 2013. View at Publisher · View at Google Scholar
  12. I. Grabowska, E. Brzoska, A. Gawrysiak et al., “Restricted myogenic potential of mesenchymal stromal cells isolated from umbilical cord,” Cell Transplantation, vol. 21, no. 8, pp. 1711–1726, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Gärtner, T. Pereira, R. Gomes et al., “Mesenchymal stem cells from extra-embryonic tissues for tissue engineering—regeneration of the peripheral nerve,” in Advances in Biomaterials Science and Biomedical Applications, R. Pignatello, Ed., InTech, Vienna, Austria, 2013. View at Google Scholar
  14. S. Dimmeler, J. Burchfield, and A. M. Zeiher, “Cell-based therapy of myocardial infarction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 2, pp. 208–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Zhang, N. Mal, M. Kiedrowski et al., “SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction,” The FASEB Journal, vol. 21, no. 12, pp. 3197–3207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar
  17. M. M. Carvalho, F. G. Teixeira, R. L. Reis, N. Sousa, and A. J. Salgado, “Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine,” Current Stem Cell Research and Therapy, vol. 6, no. 3, pp. 221–228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. M. McGrath, M. Brohlin, P. J. Kingham, L. N. Novikov, M. Wiberg, and L. N. Novikova, “Fibrin conduit supplemented with human mesenchymal stem cells and immunosuppressive treatment enhances regeneration after peripheral nerve injury,” Neuroscience Letters, vol. 516, no. 2, pp. 171–176, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. D. S. Morais, M. A. Rodrigues, M. A. Lopes et al., “Biological evaluation of alginate-based hydrogels, with antimicrobial features by Ce(III) incorporation, as vehicles for a bone substitute,” Journal of Materials Science: Materials in Medicine, vol. 24, no. 9, pp. 2145–2155, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. D. S. Morais, M. A. Rodrigues, T. I. Silva et al., “Development and characterization of novel alginate-based hydrogels as vehicles for bone substitutes,” Carbohydrate Polymers, vol. 95, no. 1, pp. 134–142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Raga, M. Sanz-Cortes, F. Bonilla, E. M. Casañ, and F. Bonilla-Musoles, “Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant,” Fertility and Sterility, vol. 92, no. 1, pp. 356–360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. F. A. Weaver, D. B. Hood, M. Zatina, L. Messina, and B. Badduke, “Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery,” Annals of Vascular Surgery, vol. 16, no. 3, pp. 286–293, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. C. Oz, J. F. Rondinone, and N. S. Shargill, “Floseal matrix: new generation topical hemostatic sealant,” Journal of Cardiac Surgery, vol. 18, no. 6, pp. 486–493, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Bensaïd, J. T. Triffitt, C. Blanchat, K. Oudina, L. Sedel, and H. Petite, “A biodegradable fibrin scaffold for mesenchymal stem cell transplantation,” Biomaterials, vol. 24, no. 14, pp. 2497–2502, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Pereira, A. Gärtner, I. Amorim et al., “Development of a skeletal muscle injury model in the rat and in vivo evaluation of the use of Human Mesenchymal Stem Cells (HMSCs) from the umbilical cord matrix in myectomy injury treatment,” in Proceedings of the 17th annual Congress of the European College of Sport Science, Bruges, Belgium, 2012.
  26. P. R. Baraniak and T. C. McDevitt, “Stem cell paracrine actions and tissue regeneration,” Regenerative Medicine, vol. 5, no. 1, pp. 121–143, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Amado, M. J. Simões, P. A. S. Armada da Silva et al., “Use of hybrid chitosan membranes and N1E-115 cells for promoting nerve regeneration in an axonotmesis rat model,” Biomaterials, vol. 29, no. 33, pp. 4409–4419, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. ISO/TC; ISO 10993-6:2007(E), Biological Evaluation of Medical Devices: Part 6 in Tests for Local Effects after Implantation, 2007.
  29. T. Pereira, A. Gärtner, I. Amorim et al., “In vivo evaluation of muscular regeneration treated with Human Mesenchymal Stem Cells (HMSCs) from the umbilical cord matrix and different biomaterials in a rat anterior tibial myectomy model,” Journal of Tissue Engineering and Regenerative Medicine, vol. 6, p. 396, 2012. View at Google Scholar
  30. J. L. Santos, C. O. Kieling, L. Meurer et al., “The extent of biliary proliferation in liver biopsies from patients with biliary atresia at portoenterostomy is associated with the postoperative prognosis,” Journal of Pediatric Surgery, vol. 44, no. 4, pp. 695–701, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. W. R. Prather, A. Toren, M. Meiron, R. Ofir, C. Tschope, and E. Horwitz, “The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemi,” Cytotherapy, vol. 11, no. 4, pp. 427–434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Sarugaser, D. Lickorish, D. Baksh, M. M. Hosseini, and J. E. Davies, “Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors,” Stem Cells, vol. 23, no. 2, pp. 220–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Parekkadan and J. M. Milwid, “Mesenchymal stem cells as therapeutics,” Annual Review of Biomedical Engineering, vol. 12, pp. 87–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. N. I. Kalinina, V. Y. Sysoeva, K. A. Rubina, Y. V. Parfenova, and V. A. Tkachuk, “Mesenchymal stem cells in tissue growth and repair,” Acta Naturae, vol. 3, no. 4, pp. 30–37, 2011. View at Google Scholar
  35. A. C. Maurício, A. Gärtner, P. Armada-da-Silva et al., “Cellular systems and biomaterials for nerve regeneration in neurotmesis injuries,” in Biomaterials Applications for Nanomedicine, P. R. Pignatello, Ed., InTch, 2011. View at Google Scholar
  36. K. le Blanc and O. Ringden, “Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation,” Biology of Blood and Marrow Transplantation, vol. 11, no. 5, pp. 321–334, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. T. A. E. Ahmed, E. V. Dare, and M. Hincke, “Fibrin: a versatile scaffold for tissue engineering applications,” Tissue Engineering Part B: Reviews, vol. 14, no. 2, pp. 199–215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. C. A. van Blitterswijk, L. Moroni, J. Rouwkema, R. Siddappa, and J. Sohier, “Tissue engineering—an introduction,” in Tissue Engineering, C. A. van Blitterswijk, P. Thomsen, A. Lindahl et al., Eds., pp. 12–36, Academic Press, Burlington, Vt, USA, 2008. View at Publisher · View at Google Scholar
  39. H.-S. Wang, S.-C. Hung, S.-T. Peng et al., “Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord,” Stem Cells, vol. 22, no. 7, pp. 1330–1337, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. Y.-S. Fu, Y.-C. Cheng, M.-Y. A. Lin et al., “Conversion of human umbilical cord mesenchymal stem cells in Wharton's Jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism,” Stem Cells, vol. 24, no. 1, pp. 115–124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. A. J. Marcus and D. Woodbury, “Fetal stem cells from extra-embryonic tissues: do not discard,” Journal of Cellular and Molecular Medicine, vol. 12, no. 3, pp. 730–742, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. A. C. Maurício, A. Gärtner, P. Armada-da-Silva et al., “Cellular systems and biomaterials for nerve regeneration in neurotmesis injuries,” in Biomaterials Applications for Nanomedicine, R. Pignatello, Ed., InTech, 2011. View at Google Scholar
  43. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Gärtner, T. Pereira, P. A. S. Armada-da-Silva et al., “Effects of umbilical cord tissue mesenchymal stem cells (UCX) on rat sciatic nerve regeneration after neurotmesis injuries,” Journal of Stem Cells and Regenerative Medicine, vol. 10, no. 1, pp. 14–26, 2014. View at Google Scholar · View at Scopus
  45. W. M. Jackson, L. J. Nesti, and R. S. Tuan, “Mesenchymal stem cell therapy for attenuation of scar formation during wound healing,” Stem Cell Research and Therapy, vol. 3, no. 3, article 20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. A. I. Caplan and J. E. Dennis, “Mesenchymal stem cells as trophic mediators,” Journal of Cellular Biochemistry, vol. 98, no. 5, pp. 1076–1084, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Chen, E. E. Tredget, P. Y. G. Wu, Y. Wu, and Y. Wu, “Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing,” PLoS ONE, vol. 3, no. 4, Article ID e1886, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Li, S. Zhang, Y. Zhang, B. Yu, Y. Xu, and Z. Guan, “Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure,” Molecular Biology Reports, vol. 36, no. 4, pp. 725–731, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Ren, L. Zhang, X. Zhao et al., “Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide,” Cell Stem Cell, vol. 2, no. 2, pp. 141–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. J. M. Karp and G. S. Leng Teo, “Mesenchymal stem cell homing: the devil is in the details,” Cell Stem Cell, vol. 4, no. 3, pp. 206–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. G. Q. Daley and D. T. Scadden, “Prospects for stem cell-based therapy,” Cell, vol. 132, no. 4, pp. 544–548, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Shin and D. A. Peterson, “Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells,” Stem Cells Translational Medicine, vol. 2, no. 1, pp. 33–42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. Y.-C. Shang, S.-H. Wang, F. Xiong et al., “Wnt3a signaling promotes proliferation, myogenic differentiation, and migration of rat bone marrow mesenchymal stem cells,” Acta Pharmacologica Sinica, vol. 28, no. 11, pp. 1761–1774, 2007. View at Publisher · View at Google Scholar · View at Scopus